MERRIMACK PHARMACEUTICALS IN's ticker is MACKXXXX and the CUSIP is 590328100. A total of 144 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q4 2014. The put-call ratio across all filers is 2.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $110,000 | -41.2% | 89,020 | +46.5% | 0.00% | -40.0% |
| Q1 2017 | $187,000 | +70.0% | 60,785 | +125.6% | 0.01% | +66.7% |
| Q4 2016 | $110,000 | -71.6% | 26,938 | -62.5% | 0.00% | -62.5% |
| Q2 2016 | $388,000 | +58.4% | 71,925 | +145.5% | 0.01% | +14.3% |
| Q1 2016 | $245,000 | -11.6% | 29,296 | +30.6% | 0.01% | +40.0% |
| Q2 2015 | $277,000 | +74.2% | 22,433 | +59.6% | 0.01% | +66.7% |
| Q4 2014 | $159,000 | +101.3% | 14,053 | -9.9% | 0.00% | +200.0% |
| Q1 2014 | $79,000 | +12.9% | 15,603 | -15.1% | 0.00% | 0.0% |
| Q3 2013 | $70,000 | – | 18,387 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DAFNA Capital Management LLC | 514,853 | $2,595,000 | 2.23% |
| GARRISON BRADFORD & ASSOCIATES INC | 98,001 | $494,000 | 0.48% |
| Catalyst Capital Advisors LLC | 380,896 | $1,920,000 | 0.44% |
| Knoll Capital Management, LLC | 160,585 | $809,000 | 0.42% |
| Tekla Capital Management LLC | 757,050 | $3,816,000 | 0.38% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 524,800 | $2,645,000 | 0.13% |
| Integre Asset Management, LLC | 103,493 | $522,000 | 0.12% |
| CAMBRIDGE TRUST CO | 220,003 | $1,109,000 | 0.10% |
| JAMISON EATON & WOOD INC /NJ | 62,782 | $316,000 | 0.09% |
| STONERIDGE INVESTMENT PARTNERS LLC | 88,304 | $445,000 | 0.09% |